Tepilamide Fumarate as a Novel Potentiator of Virus-Based Therapy.

Autor: Alwithenani, Akram^1,2,3 (AUTHOR), Arulanandam, Rozanne¹ (AUTHOR), Wong, Boaz^1,2 (AUTHOR), Spinelli, Marcus M.¹ (AUTHOR), Chen, Andrew¹ (AUTHOR), Maznyi, Glib¹ (AUTHOR), Gilchrist, Victoria H.^1,2,4 (AUTHOR), Alain, Tommy^2,4 (AUTHOR), Diallo, Jean-Simon^1,2 (AUTHOR) jsdiallo@ohri.ca

Publikováno v: Viruses (1999-4915). Jun2024, Vol. 16 Issue 6, p920. 16p.

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy

Autor: Wong, Boaz, Bergeron, Anabel, Maznyi, Glib, Ng, Kristy, Jirovec, Anna, Birdi, Harsimrat K., Serrano, Daniel, Spinelli, Marcus, Thomson, Max, Taha, Zaid, Alwithenani, Akram, Chen, Andrew, Lorimer, Ian, Vanderhyden, Barbara, Arulanandam, Rozanne, Diallo, Jean-Simon

Publikováno v: In Molecular Therapy 1 November 2023 31(11):3176-3192

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR.

Autor: Alwithenani, Akram^1,2 (AUTHOR), Bethune, Drew³ (AUTHOR), Castonguay, Mathieu¹ (AUTHOR), Drucker, Arik⁴ (AUTHOR), Flowerdew, Gordon⁵ (AUTHOR), Forsythe, Marika¹ (AUTHOR), French, Daniel³ (AUTHOR), Fris, John¹ (AUTHOR), Greer, Wenda¹ (AUTHOR), Henteleff, Harry³ (AUTHOR), MacNeil, Mary⁴ (AUTHOR), Marignani, Paola⁶ (AUTHOR), Morzycki, Wojciech⁴ (AUTHOR), Plourde, Madelaine³ (AUTHOR), Snow, Stephanie⁴ (AUTHOR), Marcato, Paola⁷ (AUTHOR) zxu3@dal.ca, Xu, Zhaolin¹ (AUTHOR) zxu3@dal.ca

Publikováno v: PLoS ONE. 5/6/2021, Vol. 16 Issue 5, p1-16. 16p.

Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers.

Autor: Alwithenani, Akram, Althubiti, Mohammad

Publikováno v: Saudi Journal of Medicine & Medical Sciences; May-Aug2020, Vol. 8 Issue 2, p95-104, 10p